Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON
EQUITY, RELATED STOCKHOLDERS MATTERS, AND ISSUER PURCHASE OF EQUITY SECURITIES.
Market Information
Our common stock is listed
for quotation on the NYSE American under the symbol “ATNM”.
Holders
As of March 31, 2023, there
were 25,729,370 shares of common stock issued and outstanding, which were held by approximately 100 holders of record. There are no shares
of preferred stock outstanding.
Dividends
We have never declared or paid
any cash dividends on our common stock. For the foreseeable future, it is expected that earnings, if any, generated from our operations
will be used to finance the growth of our business, and that no dividends will be paid to holders of our common stock. The decision to
pay dividends is at the discretion of our Board of Directors and depends upon our financial condition, results of operations, capital
requirements, and other factors that our Board of Directors deems relevant.
Securities Authorized for Issuance under Equity
Compensation Plans
We currently have three equity
compensation plans defined as follows:
The Company’s 2019 Amended
and Restated Stock Plan has an expiration date of October 18, 2029 and the number of shares of our common stock authorized under the plan
for grant to employees, directors and consultants is 9,333,333 shares.
The Company’s 2013 Amended
and Restated Stock Plan has an expiration date of September 9, 2023 and after a number of amendments approved by stockholders, the number
of shares of our common stock authorized under the plan for grant to employees, directors and consultants is 758,333 shares.
The Company’s 2013 Equity
Incentive Plan has an expiration date of September 9, 2023 and the number of shares of our common stock authorized under the plan for
grant to employees, directors and consultants under the plan is 33,333 shares.
The following table indicates
shares of common stock authorized for issuance under our equity compensation plans as of December 31, 2022:
Plan category
Number of
securities to
be issued
upon exercise
of outstanding
options and restricted stock units
(1)
Weighted-
average
exercise
price of
outstanding
options and restricted
stock units
(2)
Number of
securities
remaining
available
for future
issuance
Equity compensation plans approved by security holders
3,721,429
$ 8.00
6,383,638
Equity compensation plans not approved by security holders
-
-
-
Total
3,721,429
$ 8.00
6,383,638
(1)
Includes shares issuable upon the conversion of outstanding restricted stock units (“RSUs”).
(2) The Weighted Average Exercise Price column does not include an
amount for outstanding RSUs.
ITEM 6. RESERVED.
56
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.